Regulation of Trespin expression by modulators of cell growth, differentiation, and apoptosis in prostatic epithelial cells

Experimental Cell Research

Volumn 284, Issue 2, 2003, Pages 301-313

  Stewart, LaMonica V ^b,d   Song, Kyung ^a   Hsing, Andrew Y ^b,e   Danielpour, David ^a,c  

^a CASE WESTERN RESERVE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b NATIONAL CANCER INSTITUTE   (United States)

^c Ireland Cancer Center   (United States)

^d BAYLOR COLLEGE OF MEDICINE   (United States)

^e NONE   (United States)

Author keywords

Apoptosis; Dexamethasone; Differentiation; IGF I; ov serpin; Prostate; TGF ; Trespin

Indexed keywords

DEXAMETHASONE; MESSENGER RNA; PHORBOL ESTER 12 O TETRADECANOYLPHORBOL 13 ACETATE; PHORBOL ESTER DERIVATIVE; SERINE PROTEINASE INHIBITOR; SOMATOMEDIN C; STRESS ACTIVATED PROTEIN KINASE; TRANSFORMING GROWTH FACTOR BETA1; TRESPIN; UNCLASSIFIED DRUG;

ANIMAL CELL; APOPTOSIS; ARTICLE; CELL DIFFERENTIATION; CELL GROWTH; CELL LINE; CELL TYPE; CONTROLLED STUDY; EMBRYO CELL; ENZYME PHOSPHORYLATION; EPITHELIUM CELL; GROWTH INHIBITION; GROWTH REGULATION; HUMAN; HUMAN CELL; KIDNEY CELL; NONHUMAN; NORTHERN BLOTTING; PRIORITY JOURNAL; PROSTATE EPITHELIUM; PROTEIN DEPLETION; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN VARIANT; RAT STRAIN; REGULATORY MECHANISM; UPREGULATION;

RATTUS NORVEGICUS;

EID: 0347926504     PISSN: 00144827     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0014-4827(02)00037-X     Document Type: Article

References (49)

1. Silverman G.A., Bird P.I., Carrell R.W., Church F.C., Coughlin P.B., Gettins P.G., Irving J.A., Lomas D.A., Luke C.J., Moyer R.W., Pemberton P.A., Remold-O'Donnell E., Salvesen G.S., Travis J., Whisstock J.C. The serpins are an expanding superfamily of structurally similar but functionally diverse proteins. Evolution, mechanism of inhibition, novel functions, and a revised nomenclature. J. Biol. Chem. 276:2001;33293-33296.
2. Carrell R., Travis J. α1-antitrypsin and the serpins variation and countervariation . Trends Biochem. Sci. 85:1985;20-24.
3. Remold-O'Donnell E. The ovalbumin family of serpin proteins. FEBS Lett. 315:1993;105-108.
4. Irving J.A., Shushanov S.S., Pike R.N., Popova E.Y., Bromme D., Coetzer T.H., Bottomley S.P., Boulynko I.A., Grigoryev S.A., Whisstock J.C. Inhibitory activity of a heterochromatin-associated serpin (MENT) against papain-like cysteine proteinases affects chromatin structure and blocks cell proliferation. J. Biol. Chem. 277:2002;13192-13201.
5. Schick C., Pemberton P.A., Shi G.P., Kamachi Y., Cataltepe S., Bartuski A.J., Gornstein E.R., Bromme D., Chapman H.A., Silverman G.A. Cross-class inhibition of the cysteine proteinases cathepsins K, L, and S by the serpin squamous cell carcinoma antigen 1 a kinetic analysis . Biochemistry. 37:1998;5258-5266.
6. Schick C., Kamachi Y., Bartuski A.J., Cataltepe S., Schechter N.M., Pemberton P.A., Silverman G.A. Squamous cell carcinoma antigen 2 is a novel serpin that inhibits the chymotrypsin-like proteinases cathepsin G and mast cell chymase. J. Biol. Chem. 272:1997;1849-1855.
7. Dahlen J.R., Foster D.C., Kisiel W. Inhibition of neutrophil elastase by recombinant human proteinase inhibitor 9. Biochim. Biophys. Acta. 1451:1999;233-241.
8. Bird C.H., Sutton V.R., Sun J., Hirst C.E., Novak A., Kumar S., Trapani J.A., Bird P.I. Selective regulation of apoptosis the cytotoxic lymphocyte serpin proteinase inhibitor 9 protects against granzyme B-mediated apoptosis without perturbing the Fas cell death pathway . Mol. Cell. Biol. 18:1998;6387-6398.
9. Annand R.R., Dahlen J.R., Sprecher C.A., De Dreu P., Foster D.C., Mankovich J.A., Talanian R.V., Kisiel W., Giegel D.A. Caspase-1 (interleukin-I beta converting enzyme) is inhibited by the human serpin analogue proteinase inhibitor 9. Biochem. J. 342:1999;655-665.
10. Miyata T., Inagi R., Nangaku M., Imasawa T., Sato M., Izuhara Y., Suzuki D., Yoshino A., Onogi H., Kimura M., Sugiyama S., Kurokawa K. Overexpression of the serpin megsin induces progressive mesangial cell proliferation and expansion. J. Clin. Invest. 109:2002;585-593.
11. Medema J.P., Schuurhuis D.H., Rea D., van Tongeren J., de Jong J., Bres S.A., Laban S., Toes M., Schumacher T.N., Bladergroen B.A., Ossend F., Kummer J.A., Melief C.J., Offringa R. Expression of the serpin serine protease inhibitor 6 protects dendritic cells from cytotoxic T lymphocyte-induced apoptosis differential modulation by T helper type 1 and type 2 cells . J. Exp. Med. 194:2001;657-667.
12. Dickinson J.L., Bates E.J., Ferrante A., Antalis T.M. Plasminogen activator inhibitor type 2 inhibits tumor necrosis factor alpha-induced apoptosis. Evidence for an alternate biological function. J. Biol. Chem. 270:1995;27894-27904.
13. Schleef R.R., Chuang T.L. Protease inhibitor 10 inhibits tumor necrosis factor alpha-induced cell death. Evidence for the formation of intracellular high M(r) protease inhibitor 10-containing complexes. J. Biol. Chem. 275:2000;26385-26389.
14. McGettrick A.F., Barnes R.C., Worrall D.M. SCCA2 inhibits TNF-mediated apoptosis in transfected HeLa cells. The reactive centre loop sequence is essential for this function and TNF-induced cathepsin G is a candidate target. Eur. J. Biochem. 268:2001;5868-5875.
15. Suminami Y., Nagashima S., Vujanovic N.L., Hirabayashi K., Kato H., Whiteside T.L. Inhibition of apoptosis in human tumour cells by the tumour-associated serpin, SCC antigen-1. Br. J. Cancer. 82:2000;981-989.
16. Murakami A., Suminami Y., Hirakawa H., Nawata S., Numa F., Kato H. Squamous cell carcinoma antigen suppresses radiation-induced cell death. Br. J. Cancer. 84:2001;851-858.
17. Chipuk J.E., Stewart L.V., Ranieri A., Song K., Danielpour D. Trespin identification and characterization of a novel rat ov-serpin family member . J. Biol. Chem. 277:2002;26412-26421.
18. Danielpour D. Transdifferentiation of NRP-152 rat prostatic basal epithelial cells toward a luminal phenotype regulation by glucocorticoids, insulin-like growth factor-I and transforming growth factor-beta . J. Cell Sci. 112:1999;169-179.
19. Hsing A.Y., Kadomatsu K., Bonham M.J., Danielpour D. Regulation of apoptosis induced by transforming growth factor-beta1 in nontumorigenic rat prostatic epithelial cell lines. Cancer Res. 56:1996;5146-5149.
20. Danielpour D., Kadomatsu K., Anzano M.A., Smith J.M., Sporn M.B. Development and characterization of nontumorigenic and tumorigenic epithelial cell lines from rat dorsal-lateral prostate. Cancer Res. 54:1994;3413-3421.
21. Church G.M., Gilbert W. Genomic sequencing. Proc. Natl. Acad. Sci. USA. 81:1984;1991-1995.
22. Scott F.L., Paddle-Ledinek J.E., Cerruti L., Coughlin P.B., Salem H.H., Bird P.I. Proteinase inhibitor 6 (PI-6) expression in human skin induction of PI-6 and a PI-6/proteinase complex during keratinocyte differentiation . Exp. Cell Res. 245:1998;263-271.
23. Wang Y., Jensen P.J. Regulation of the level and glycosylation state of plasminogen activator inhibitor type 2 during human keratinocyte differentiation. Differentiation. 63:1998;93-99.
24. Riewald M., Chuang T., Neubauer A., Riess H., Schleef R.R. Expression of bomapin, a novel human serpin, in normal/malignant hematopoiesis and in the monocytic cell lines THP-1 and AML-193. Blood. 91:1998;1256-1262.
25. Ten Dijke P., Goumans M.J., Itoh F., Itoh S. Regulation of cell proliferation by Smad proteins. J. Cell. Physiol. 191:2002;1-16.
26. Moustakas A., Souchelnytskyi S., Heldin C.H. Smad regulation in TGF-beta signal transduction. J. Cell Sci. 114:2001;4359-4369.
27. Tardif G., Reboul P., Dupuis M., Geng C., Duval N., Pelletier J.P., Martel-Pelletier J. Transforming growth factor-beta induced collagenase-3 production in human osteoarthritic chondrocytes is triggered by Smad proteins cooperation between activator protein-1 and PEA-3 binding sites . J. Rheumatol. 28:2001;1631-1639.
28. Pateder D.B., Ferguson C.M., Ionescu A.M., Schwarz E.M., Rosier R.N., Puzas J.E., O'Keefe R.J. PTHrP expression in chick sternal chondrocytes is regulated by TGF-beta through Smad-mediated signaling. J. Cell. Physiol. 188:2001;343-351.
29. Jang C.W., Chen C.H., Chen C.C., Chen J.Y., Su Y.H., Chen R.H. TGF-beta induces apoptosis through Smad-mediated expression of DAP-kinase. Nature Cell Biol. 4:2002;51-58.
30. Yanagisawa K., Osada H., Masuda A., Kondo M., Saito T., Yatabe Y., Takagi K., Takahashi T. Induction of apoptosis by Smad3 and down-regulation of Smad3 expression in response to TGF-beta in human normal lung epithelial cells. Oncogene. 17:1998;1743-1747.
31. Yamamura Y., Hua X., Bergelson S., Lodish H.F. Critical role of Smads and AP-1 complex in transforming growth factor-beta-dependent apoptosis. J. Biol. Chem. 275:2000;36295-36302.
32. Simeone D.M., Zhang L., Graziano K., Nicke B., Pham T., Schaefer C., Logsdon C.D. Smad4 mediates activation of mitogen-activated protein kinases by TGF-beta in pancreatic acinar cells. Am. J. Physiol. Cell. Physiol. 281:2001;C311-C319.
33. Rodriguez-Barbero A., Obreo J., Yuste L., Montero J.C., Rodriguez-Pena A., Pandiella A., Bernabeu C., Lopez-Novoa J.M. Transforming growth factor-beta1 induces collagen synthesis and accumulation via p38 mitogen-activated protein kinase (MAPK) pathway in cultured L(6)E(9) myoblasts. FEBS Lett. 513:2002;282-288.
34. Lai C.F., Cheng S.L. Signal transductions induced by bone morphogenetic protein-2 and transforming growth factor-beta in normal human osteoblastic cells. J. Biol. Chem. 277:2002;15514-15522.
35. Yamamoto T., Kozawa O., Tanabe K., Akamatsu S., Matsuno H., Dohi S., Uematsu T. Involvement of p38 MAP kinase in TGF-beta-stimulated VEGF synthesis in aortic smooth muscle cells. J. Cell. Biochem. 82:2001;591-598.
36. Hayashida T., Poncelet A.C., Hubchak S.C., Schnaper H.W. TGF-beta1 activates MAP kinase in human mesangial cells a possible role in collagen expression . Kidney Int. 56:1999;1710-1720.
37. Chin B.Y., Mohsenin A., Li S.X., Choi A.M., Choi M.E. Stimulation of pro-alpha(1)(I) collagen by TGF-beta(1) in mesangial cells role of the p38 MAPK pathway . Am. J. Physiol. Renal Physiol. 280:2001;F495-F504.
38. Kutz S.M., Hordines J., McKeown-Longo P.J., Higgins P.J. TGF-beta1-induced PAI-1 gene expression requires MEK activity and cell-to-substrate adhesion. J. Cell Sci. 114:2001;3905-3914.
39. Hu P.P., Shen X., Huang D., Liu Y., Counter C., Wang X.F. The MEK pathway is required for stimulation of p21 (WAF1/CIP1) by transforming growth factor-beta. J. Biol. Chem. 274:1999;35381-35387.
40. Kucich U., Rosenbloom J.C., Shen G., Abrams W.R., Hamilton A.D., Sebti S.M., Rosenbloom J. TGF-beta1 stimulation of fibronectin transcription in cultured human lung fibroblasts requires active geranylgeranyl transferase I, phosphatidylcholine-specific phospholipase C, protein kinase C-delta, and p38, but not erk1/erk2. Arch. Biochem. Biophys. 374:2000;313-324.
41. Hocevar B.A., Brown T.L., Howe P.H. TGF-beta induces fibronectin synthesis through a c-Jun N-terminal kinase-dependent, Smad4-independent pathway. EMBO J. 18:1999;1345-1356.
42. Rousse S., Lallemand F., Montarras D., Pinset C., Mazars A., Prunier C., Atfi A., Dubois C. Transforming growth factor-beta inhibition of insulin-like growth factor-binding protein-5 synthesis in skeletal muscle cells involves a c-Jun N-terminal kinase-dependent pathway. J. Biol. Chem. 276:2001;46961-46967.
43. Yoshizumi M., Wang H., Hsieh C.M., Sibinga N.E., Perrella M.A., Lee M.E. Down-regulation of the cyclin A promoter by transforming growth factor-beta1 is associated with a reduction in phosphorylated activating transcription factor-1 and cyclic AMP-responsive element-binding protein. J. Biol. Chem. 272:1997;22259-22264.
44. Engel M.E., McDonnell M.A., Law B.K., Moses H.L. Interdependent SMAD and JNK signaling in transforming growth factor-beta-mediated transcription. J. Biol. Chem. 274:1999;37413-37420.
45. Yan Z., Kim G.Y., Deng X., Friedman E. Transforming growth factor beta 1 induces proliferation in colon carcinoma cells by Ras-dependent, smad-independent down-regulation of p21cip1. J. Biol. Chem. 277:2002;9870-9879.
46. Young J.L., Sukhova G.K., Foster D., Kisiel W., Libby P., Schonbeck U. The serpin proteinase inhibitor 9 is an endogenous inhibitor of interleukin1beta-converting enzyme (caspase-1) activity in human vascular smooth muscle cells. J. Exp. Med. 191:2000;1535-1544.
47. Bruckheimer E.M., Kyprianou N. Dihydrotestosterone enhances transforming growth factor-beta-induced apoptosis in hormone-sensitive prostate cancer cells. Endocrinology. 142:2001;2419-2426.
48. Guo Y., Kyprianou N. Restoration of transforming growth factor beta signaling pathway in human prostate cancer cells suppresses tumorigenicity via induction of caspase-1-mediated apoptosis. Cancer Res. 59:1999;1366-1371.
49. Chipuk J.E., Bhat M., Hsing A.Y., Ma J., Danielpour D. Bcl-xL blocks transforming growth factor-beta 1-induced apoptosis by inhibiting cytochrome c release and not by directly antagonizing Apaf-1-dependent caspase activation in prostate epithelial cells. J. Biol. Chem. 276:2001;26614-26621.